Neurona Therapeutics
Cell therapies for neural circuit repair
- Sector
- Biotech
- Headquarters
- SOUTH SAN FRANCISCO, CA
- Latest Form D
- $102M, Apr 2025
- Total capital
- $283M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $283M
- 6 Form D · last Apr 2025
- 19 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 6 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 6th filing$102M
- Private capital raisedForm D · SEC · 5th filing$120M
- Private capital raisedForm D · SEC · 4th filing$28.3M
- Private capital raisedForm D · SEC · 3rd filing$15M
- Private capital raisedForm D · SEC · 2nd filing$10M
- Private capital raisedForm D · SEC · 1st filing$7.6M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Arnold KriegsteinDirectorNamed in SEC Form D filings
- Brad MargusDirectorNamed in SEC Form D filings
- Cory NicholasExecutive Officer, DirectorNamed in SEC Form D filings
- David GoeddelDirectorNamed in SEC Form D filings
- Erica WhitakerDirectorNamed in SEC Form D filings
- Erica WhittakerDirectorNamed in SEC Form D filings
Show all 14 people
- James StutzExecutive OfficerNamed in SEC Form D filings
- Leo GuthartDirectorNamed in SEC Form D filings
- Peter SvennilsonDirectorNamed in SEC Form D filings
- Ray KelleherDirectorNamed in SEC Form D filings
- Robert R. TijanDirectorNamed in SEC Form D filings
- Robert TjianDirectorNamed in SEC Form D filings
- Stephen R. HauserDirectorNamed in SEC Form D filings
- Tim KutzkeyDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 6- PendingNeural Precursor Cell Populations And Uses ThereofUSPTOApplication 15766792
- PendingMethods Of Treating Seizure ActivityUSPTOApplication PCTUS2024049338
- PendingMethods Of Treating Seizure ActivityUSPTOApplication 63587407
Show all 6 patent records
- Neural Precursor Cell Populations And Uses ThereofDec 27, 2018 · Application 15766792Pending
- Methods Of Treating Seizure ActivityApplication PCTUS2024049338Pending
- Methods Of Treating Seizure ActivityApplication 63587407Pending
- Neural Precursor Cell Populations And Uses ThereofApplication PCTUS2016056316Pending
- Neural Precursor Cell Populations And Uses ThereofApplication 62239042Pending
- Methods Of Treating Seizure ActivityApplication 19524871Pending
Related companies, and why
- Metagenomi Technologies, LLCSimilar federal contract value in Biotech · null in contracts
- Harmony Biosciences II, Inc.Similar federal contract value in Biotech · null in contracts
- Dewpoint TherapeuticsSimilar federal contract value in Biotech · null in contracts
- CellanomeSimilar federal contract value in Biotech · null in contracts
- Rakuten Medical, Inc.Similar federal contract value in Biotech · null in contracts
- SeaStar Medical Holding CorpSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .